Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma.

Autor: Nijdam A; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Dekker N; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van 't Veer MB; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands., Daniels LA; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands., van der Maazen RW; Department of Radiotherapy, Radboud University Medical Centre, Nijmegen, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus Medical Centre, Rotterdam, the Netherlands., de Weijer RJ; Department of Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands., Zijlstra JM; Department of Haematology, Amsterdam UMC, Location VU Medical Centre, Amsterdam, the Netherlands., Stedema FG; Department of Haematology, University Medical Centre Groningen, Groningen, the Netherlands., Ta BD; Department of Radiotherapy, MAASTRO Clinic, Maastricht, the Netherlands., Posthuma EFM; Department of Haematology, Reinier de Graaf Group, Delft, the Netherlands., Manenschijn A; Department of Haematology, Isala, Zwolle, the Netherlands., Dielwart MFH; Department of Radiotherapy, Zeeuws Radiotherapy Institute, Vlissingen, the Netherlands., Bilgin YM; Department of Haematology, Adrz Hospital, Goes, the Netherlands., van den Heuvel MJ; Department of Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Boersma RS; Department of Haematology, Amphia Hospital, Breda, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Raemaekers JMM; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2019 Aug; Vol. 186 (4), pp. e103-e108. Date of Electronic Publication: 2019 May 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dosimetric analysis of patients receiving radiotherapy with VMAT technique in localized prostate cancer and its correlation with side effects.

Autor: Akay, Sıtkı U.¹ suakay91@hotmail.com, Çetin, İlknur A.¹, Bekiroğlu, Gülnaz N.²

Publikováno v: Journal of Cancer Research & Therapeutics. Apr-Jun2023, Vol. 19 Issue 3, p801-807. 7p.

Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.

Autor: Carrasquilla, Michael, Sholklapper, Tamir, Pepin, Abigail N., Hodgins, Nicole, Siyuan Lei, Rashid, Abdul, Danner, Malika, Zwart, Alan, Bolanos, Grecia, Ayoob, Marilyn, Yung, Thomas, Aghdam, Nima, Collins, Brian, Suy, Simeng, Kumar, Deepak, Hankins, Ryan, Kowalczyk, Keith, Dawson, Nancy, Collins, Sean

Publikováno v: Frontiers in Oncology; 2023, p1-7, 7p

Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.

Autor: Draulans, Cédric^1,2 (AUTHOR) cedric.draulans@uzleuven.be, De Roover, Robin^1,2 (AUTHOR), van der Heide, Uulke A.³ (AUTHOR), Kerkmeijer, Linda^4,5 (AUTHOR), Smeenk, Robert J.⁴ (AUTHOR), Pos, Floris³ (AUTHOR), Vogel, Wouter V.⁶ (AUTHOR), Nagarajah, James⁷ (AUTHOR), Janssen, Marcel⁷ (AUTHOR), Isebaert, Sofie^1,2 (AUTHOR), Maes, Frederik^8,9 (AUTHOR), Mai, Cindy¹⁰ (AUTHOR), Oyen, Raymond¹⁰ (AUTHOR), Joniau, Steven^11,12 (AUTHOR), Kunze-Busch, Martina⁴ (AUTHOR), Goffin, Karolien¹³ (AUTHOR), Haustermans, Karin^1,2 (AUTHOR) karin.haustermans@uzleuven.be

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. Apr2021, Vol. 48 Issue 4, p1211-1218. 8p. 2 Diagrams, 2 Charts.